NOMAD – EU consortium for smart dental implants
NOMAD; Innovation for smart dental implants
Glantreo is pleased to announce they are a key partner in the NOMAD consortium. This EU-funded research and innovation collaborative project is aimed at developing the next generation of dental implants that can prevent peri-implant diseases. Scientists and dental specialists from 10 organizations in 7 European countries have joined forces to tackle the increasing socio-economic burden associated with these diseases.
We are excited to partner with world-class companies and research groups working on smart materials to innovate in the implants space. At present, out of patients receiving dental implants, 43% develop peri-implant mucositis and 22% peri-implantitis, diseases that are painful and reduce implant efficacy. By bringing together specialists in biomaterial, nanomaterials, dentistry and microbiology, NOMAD will create the next generation of dental implants.
Glantreo is a leading technology company specialising in advanced materials for chromatography, lateral flow assays, biosensors and innovative drug-delivery nanoparticles. In the NOMAD project, Glantreo’s expertise in nanoparticle synthesis and functionalisation is being utilized to develop smart biomaterials for dental implants. Learn more about Glantreo’s cutting-edge solutions for drug delivery :
Related Acticle
Glantreo launch new SOLAD Protein A column for mAb Analysis
The SOLAD™ Protein-A column combines a 10µm sized SOLAD particle with recombinant Protein A...
Glantreo collaborate with Marama Labs to quantify brightness of Selenium Nanoparticles
Glantreo’s Selenium Nanoparticles (SeNP) combine large surface area with high colour quality to create...
Updated SeNP Passive Adsorption Guide
Glantreo's updated passive adsorption guide including steps on selecting the optimum buffer, titration of...
